Frederick Madison Allen
Frederick Madison Allen[edit]
Frederick Madison Allen (1879–1964) was an American physician and researcher who made significant contributions to the field of diabetes mellitus management. He is best known for developing the "Allen treatment" or "starvation diet" for diabetes before the discovery of insulin therapy.
Early Life and Education[edit]
Frederick Madison Allen was born in Canton, New York, in 1879. He pursued his medical education at Harvard University, where he developed an interest in metabolic diseases, particularly diabetes. After completing his studies, Allen worked at several prestigious institutions, including the Rockefeller Institute for Medical Research.
Career and Research[edit]
Allen's work focused on understanding the metabolism of carbohydrates and the role of diet in managing diabetes. At a time when diabetes was often a fatal disease, Allen's approach involved strict dietary control to manage blood sugar levels. His "starvation diet" was based on the principle of reducing carbohydrate intake to a minimum, thereby lowering blood glucose levels and prolonging the lives of diabetic patients.
The Allen Treatment[edit]
The "Allen treatment" involved a highly restrictive diet that limited caloric intake, primarily through the reduction of carbohydrates. Patients were often placed on a near-starvation diet, which, while difficult to maintain, was one of the few available methods to manage diabetes before the advent of insulin therapy. Allen's method was controversial but provided a foundation for future research into dietary management of diabetes.
Later Life and Legacy[edit]
After the discovery of insulin by Frederick Banting and Charles Best in 1921, the treatment of diabetes was revolutionized, and the need for Allen's starvation diet diminished. However, his work laid the groundwork for understanding the importance of diet in diabetes management and influenced future research in the field.
Allen continued to work in medical research and education until his retirement. He passed away in 1964, leaving behind a legacy of pioneering work in the treatment of diabetes.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian